Repare Therapeutics Statistics Share Statistics Repare Therapeutics has 42.96M
shares outstanding. The number of shares has increased by 1.05%
in one year.
Shares Outstanding 42.96M Shares Change (YoY) 1.05% Shares Change (QoQ) 0.9% Owned by Institutions (%) 60.44% Shares Floating 30.82M Failed to Deliver (FTD) Shares 20 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 644.26K, so 1.5% of the outstanding
shares have been sold short.
Short Interest 644.26K Short % of Shares Out 1.5% Short % of Float 2.21% Short Ratio (days to cover) 6.16
Valuation Ratios The PE ratio is -0.66 and the forward
PE ratio is -1.86.
Repare Therapeutics's PEG ratio is
0.06.
PE Ratio -0.66 Forward PE -1.86 PS Ratio 1.04 Forward PS 7.3 PB Ratio 0.37 P/FCF Ratio -0.73 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Repare Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.77,
with a Debt / Equity ratio of 0.01.
Current Ratio 6.77 Quick Ratio 6.77 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $414.55K Profits Per Employee $-656.5K Employee Count 129 Asset Turnover 0.3 Inventory Turnover n/a
Taxes Income Tax 1.44M Effective Tax Rate -1.73%
Stock Price Statistics The stock price has increased by -50.87% in the
last 52 weeks. The beta is 0.93, so Repare Therapeutics's
price volatility has been higher than the market average.
Beta 0.93 52-Week Price Change -50.87% 50-Day Moving Average 1.62 200-Day Moving Average 1.41 Relative Strength Index (RSI) 50.63 Average Volume (20 Days) 288,311
Income Statement In the last 12 months, Repare Therapeutics had revenue of 53.48M
and earned -84.69M
in profits. Earnings per share was -2.
Revenue 53.48M Gross Profit 40.1M Operating Income -93.52M Net Income -84.69M EBITDA -90.22M EBIT -92.14M Earnings Per Share (EPS) -2
Full Income Statement Balance Sheet The company has 84.72M in cash and 1.93M in
debt, giving a net cash position of 82.78M.
Cash & Cash Equivalents 84.72M Total Debt 1.93M Net Cash 82.78M Retained Earnings -417.8M Total Assets 130.49M Working Capital 106.49M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -76.44M
and capital expenditures 0, giving a free cash flow of -76.44M.
Operating Cash Flow -76.44M Capital Expenditures n/a Free Cash Flow -76.44M FCF Per Share -1.8
Full Cash Flow Statement Margins Gross margin is 74.98%, with operating and profit margins of -174.88% and -158.37%.
Gross Margin 74.98% Operating Margin -174.88% Pretax Margin -155.67% Profit Margin -158.37% EBITDA Margin -168.71% EBIT Margin -174.88% FCF Margin -142.95%
